For instance, patients treated with mammalian target of rapamycin (mTOR) inhibitors display a very low incidence of HCMV. The incidence of HCMV also correlates with the type of transplant: about 50% among pancreas or kidney–pancreas recipients, 50–75% in lung or heart–lung r...